Flag Ship Acquisition Corp. (NASDAQ:ETHZ – Free Report)’s stock is set to reverse split before the market opens on Monday, October 20th. The 1-10 reverse split was announced on Wednesday, October 15th. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, October 17th.
Flag Ship Acquisition Stock Down 4.7%
ETHZ stock opened at $1.83 on Thursday. The company has a market cap of $300.91 million, a P/E ratio of -0.12 and a beta of 0.38. Flag Ship Acquisition has a 1 year low of $0.66 and a 1 year high of $17.75.
Analyst Upgrades and Downgrades
ETHZ has been the subject of a number of research analyst reports. Wall Street Zen cut shares of Flag Ship Acquisition to a “strong sell” rating in a research report on Saturday, August 30th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Flag Ship Acquisition in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has an average rating of “Sell”.
Flag Ship Acquisition Company Profile
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor.
Featured Articles
- Five stocks we like better than Flag Ship Acquisition
- What is a Stock Market Index and How Do You Use Them?
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- What to Know About Investing in Penny Stocks
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- Canada Bond Market Holiday: How to Invest and Trade
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Flag Ship Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Flag Ship Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.